Log in to save to my catalogue
Log in to save to my catalogue

U.S. Patent and Trademark Office Receives Comabella Manuel, Montalban Xavier and Teva Pharmaceutical...

| Ask | Become a Library member

U.S. Patent and Trademark Office Receives Comabella Manuel, Montalban Xavier and Teva Pharmaceutical...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1518907745

U.S. Patent and Trademark Office Receives Comabella Manuel, Montalban Xavier and Teva Pharmaceutical Industries Ltd's Patent Application for Biomarkers Predictive for Clinical Response for Glatiramer Acetate

About this item

Full title

U.S. Patent and Trademark Office Receives Comabella Manuel, Montalban Xavier and Teva Pharmaceutical Industries Ltd's Patent Application for Biomarkers Predictive for Clinical Response for Glatiramer Acetate

Publisher

New Delhi: Pedia Content Solutions Pvt. Ltd

Journal title

Global IP News. Pharmaceutical Patent News, 2014

Language

English

Formats

Newsletter articles

Publication information

Publisher

New Delhi: Pedia Content Solutions Pvt. Ltd

More information

Alternative Titles

Full title

U.S. Patent and Trademark Office Receives Comabella Manuel, Montalban Xavier and Teva Pharmaceutical Industries Ltd's Patent Application for Biomarkers Predictive for Clinical Response for Glatiramer Acetate

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_1518907745

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1518907745

How to access this item

Log in as a Library member

View record in ProQuest

View in old catalogue

Connecting people and collections